Form 4 for LQDA Liquidia Corp
Accepted 2025-09-02 00:00:00 ET · period of report 2025-08-28 · accession 0001104659-25-086436 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-09-02 | 2025-08-28 | LQDA | Saggar Rajeev | Chief Medical Off | S - Sale | $27.85 | -20.0K | 249.7K | -7% | -$557.0K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-08-28 | S | D | 20,000 | $27.85 | 249,727 | D | — | — | (F2) Price is the volume weighted average price of all transactions made by the Reporting Person on the transaction date for prices ranging from $27.22 to $28.53. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. (F3) Includes (i) 31,249 unvested RSUs of the 83,333 RSUs granted to the Reporting Person on January 11, 2023, (ii) 35,307 unvested RSUs of the 56,492 RSUs granted to the Reporting Person on January 11, 2024, (iii) 71,780 RSUs granted to the Reporting Person on January 11, 2025, none of which have vested as of the date of this Form 4, and (iv) 7,131 shares of common stock acquired under the Liquidia Corporation 2020 Employee Stock Purchase Plan. |